Large gap with delayed quotes
|
Last quote
04/15/2026
-
23:20:00
|
Bid
04/15/2026 -
21:59:59
|
Bid Volume |
Ask
04/15/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
441.70
-2.58
(
-0.58% )
|
441.62
|
760 |
441.77
|
480 |
Analysis date: 10.04.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 03.04.2026.
Interest
Weak
Weak
Two stars since 03.04.2026.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 03.04.2026 at a price of 438.71.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 17.03.2026.
4wk Rel Perf
-13.12%
-13.12%
The four-week dividend-adjusted underperformance versus SP500 is 13.12%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 20.02.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.14%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.20%.
Mkt Cap in $bn
110.83
110.83
With a market capitalization >$8bn, VERTEX PHARMA INC is considered a large-cap stock.
G/PE Ratio
0.80
0.80
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
18.62
18.62
The estimated PE is for the year 2028.
LT Growth
14.80%
14.80%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
25
25
Over the last seven weeks, an average of 25 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
57
57
For 1% of index variation, the stock varies on average by 0.57%.
Correlation
0.25
0.25
Stock movements are strongly independent of index variations.
Value at Risk
57.40
57.40
The value at risk is estimated at USD 57.40. The risk is therefore 13.16%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002